Figure 2.
Lower relative abundance of H4-K12acK16ac in HRD versus non-HRD tumors. (A) H4-K12acK16ac was measured by PRM in 45 HRD and 35 non-HRD tumors. (B) Quantifiable levels of H4-K12acK16ac were detected in 64 (34 HRD and 30 non-HRD) of the tumors that were analyzed by iTRAQ and PRM.